Liat Goldberg

Title: Liat Goldberg: Innovator in Cancer Treatment

Introduction

Liat Goldberg is a prominent inventor based in Givatayim, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing novel pharmaceutical compositions aimed at combating various forms of cancer.

Latest Patents

Goldberg's latest patents include groundbreaking methods for treating cancer. One of her notable inventions is the development of alkoxyalkyl S-prenylthiosalicylates for the treatment of cancer. This patent discloses pharmaceutical compositions containing these compounds, which can be administered to patients afflicted with solid tumors or hematological malignancies. Another significant patent involves cancer treatment using FTS and 2-deoxyglucose. This method outlines the administration of effective amounts of a Ras antagonist, comprising FTS or its analogs, along with 2-deoxyglucose, to patients in need of treatment.

Career Highlights

Throughout her career, Liat Goldberg has worked with esteemed institutions such as Tel Aviv University and Kadmon Corporation, LLC. Her research has been instrumental in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Goldberg has collaborated with notable colleagues, including Yoel Kloog and Michael Jay Brownstein. These partnerships have further enriched her research and contributed to the development of her innovative treatments.

Conclusion

Liat Goldberg's contributions to cancer treatment through her patents and research highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical science and offers hope for improved therapies for cancer patients.